Tizanidine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 13 USDMF, 1 CEP/COS, 6 JDMF, 5 EU WC, 3 KDMF, 8 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 76 FDA Orange Book, 9 Europe, 2 Canada, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 2MG BASE, CAPSULE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 6MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 4 SPI Pharma, 10 DKSH, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 42 Fillers, Diluents & Binders, 28 Direct Compression, 25 Granulation, 22 Thickeners and Stabilizers, 17 Controlled & Modified Release, 17 Disintegrants & Superdisintegrants, 13 Taste Masking, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Lubricants & Glidants, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 5 Emulsifying Agents, 5 Topical, 5 Rheology Modifiers, 5 Coloring Agents, 4 Solubilizers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Parenteral, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

11 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20397 / DOSAGE - TABLET;ORAL - EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TIZANIDINE HYDROCHLORIDE(UNII: B53E3NMY5C) (TIZANIDINE - UNII:6AI06C00GW)	TIZANIDINE	4mg

Inactive Ingredients

Ingredient Name	Acorda Therapeutics, Inc.	PD-Rx Pharmaceuticals, Inc.
ANHYDROUS LACTOSE(3SY5LH9PMK)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
GELATIN(2G86QN327L)
SILICON DIOXIDE(ETJ7Z6XBU4)
STEARIC ACID(4ELV7Z65AP)
TITANIUM DIOXIDE(15FIX9V2JP)

Setid 338c33be 9578 40e8 Bdff 64b4e1b74a2c Applno 20397 Form Tablet Oral Dosage Eq 2mg Base - Drug Product Composition: Tizanidine Hydrochloride